Article
Epigenetic regulators and their impact on therapy in acute myeloid leukemia
29 Feb 2016
Abstract excerpt
Genomic studies of hematologic malignancies have identified a spectrum of recurrent somatic alterations that contribute to acute myeloid leukemia initiation and maintenance, and which confer sensitivities to molecularly targeted therapies. The majority of these genetic events are small, site-specific alterations in DNA sequence. In more than two thirds of patients with de novo acute myeloid leukemia mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
